Revenue, last quarter
$302.3M
+32% vs same quarter last year
Net income
$9.6M
+58.5% vs same quarter last year
EPS, diluted
$0.26
+52.9% vs same quarter last year
Operating cash flow
$25.1M
+80.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $947.7M | $29.6M |
| FY24 | $695.2M | $22.6M |
| FY23 | $544.9M | $13.4M |
| FY22 | $473.2M | $6.6M |
| FY21 | $439.7M | $2.7M |
| FY20 | $391M | $15.7M |
| FY19 | $338.5M | $2.5M |
| FY18 | $286.1M | $15.7M |
| FY17 | $251M | $9.9M |
| FY16 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 5.5% | 3.1% |
| FY24 | 5.5% | 3.2% |
| FY23 | 4.6% | 2.5% |
| FY22 | 2.7% | 1.4% |
| FY21 | 1.1% | 0.6% |
| FY20 | 4.8% | 4% |
| FY19 | 1.7% | 0.8% |
| FY18 | 7.2% | 5.5% |
| FY17 | 6.1% | 3.9% |
| FY16 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $36.3M |
| FY24 | $30.3M |
| FY23 | $25M |
| FY22 | −$5.1M |
| FY21 | −$24.5M |
| FY20 | $43M |
| FY19 | $2.8M |
| FY18 | $19.7M |
| FY17 | $14.1M |
| FY16 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | - | - |
| FY24 | - | - |
| FY23 | - | - |
| FY22 | - | $0 |
| FY21 | $0 | $0 |
| FY20 | $0 | $65K |
| FY19 | $11.6M | $0 |
| FY18 | $0 | $0 |
| FY17 | $0 | - |
| FY16 | - | - |
- Pennant
- Healthcare median
Show the numbers
| Year | Pennant | Healthcare median |
|---|---|---|
| FY25 | 3.1% | −30.6% |
| FY24 | 3.2% | −47% |
| FY23 | 2.5% | −58% |
| FY22 | 1.4% | −80.4% |
| FY21 | 0.6% | −71.8% |
| FY20 | 4% | −62.2% |
| FY19 | 0.8% | −46.2% |
| FY18 | 5.5% | −49.6% |
| FY17 | 3.9% | −45.9% |
| FY16 | - | −36% |